Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Frebourg

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|July 28, 2001
Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndromeJ M Limacher, T Frebourg, S Natarajan-Ame, et al.
The Journal of Urology|June 24, 1999
p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapyC Pfister, J M Flaman, F Dunet, et al.
The Journal of Urology|May 20, 1999
Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumorsC Pfister, J M Flaman, C Martin, et al.
British Journal of Cancer|December 9, 2010
Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancerF Di Fiore, R Sesboüé, P Michel, et al.
Experimental Cell Research|July 1, 1992
Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell lineN Modjtahedi, T Frebourg, N Fossar, et al.
Cancer Research|February 15, 1994
Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotypeT Frebourg, M Sadelain, Y S Ng, et al.
Cancer Research|May 1, 1995
Alternative splicing of MLH1 messenger RNA in human normal cellsF Charbonnier, C Martin, M Scotte, et al.
Biochimica Et Biophysica Acta|May 29, 1998
Structural and functional analysis of the 5'-transcription control region for the human alpha2-HS glycoprotein geneF Banine, C Gangneux, J P Lebreton, et al.
Oncogene|April 18, 1998
Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeastJ M Flaman, V Robert, S Lenglet, et al.
Cancer Research|December 15, 1992
A functional screen for germ line p53 mutations based on transcriptional activationT Frebourg, N Barbier, J Kassel, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|July 28, 2001
Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndromeJ M Limacher, T Frebourg, S Natarajan-Ame, et al.
The Journal of Urology|June 24, 1999
p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapyC Pfister, J M Flaman, F Dunet, et al.
The Journal of Urology|May 20, 1999
Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumorsC Pfister, J M Flaman, C Martin, et al.
British Journal of Cancer|December 9, 2010
Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancerF Di Fiore, R Sesboüé, P Michel, et al.
Experimental Cell Research|July 1, 1992
Increased expression of cytokeratin and ferritin-H genes in tumorigenic clones of the SW 613-S human colon carcinoma cell lineN Modjtahedi, T Frebourg, N Fossar, et al.
Cancer Research|February 15, 1994
Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotypeT Frebourg, M Sadelain, Y S Ng, et al.
Cancer Research|May 1, 1995
Alternative splicing of MLH1 messenger RNA in human normal cellsF Charbonnier, C Martin, M Scotte, et al.
Biochimica Et Biophysica Acta|May 29, 1998
Structural and functional analysis of the 5'-transcription control region for the human alpha2-HS glycoprotein geneF Banine, C Gangneux, J P Lebreton, et al.
Oncogene|April 18, 1998
Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeastJ M Flaman, V Robert, S Lenglet, et al.
Cancer Research|December 15, 1992
A functional screen for germ line p53 mutations based on transcriptional activationT Frebourg, N Barbier, J Kassel, et al.
Pageof 11